期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

神经功能损伤评分在大鼠脑缺血实验中的应用 被引量：20

The Application of Neurological Deficit Scoring in Cerebral Ischemia Rats
下载PDF
导出
摘要 脑梗塞发病率逐年增高,它严重影响了患者的生活质量。临床上,神经功能损伤评分是诊断和疗效评价的重要指标。在临床前研究中,神经功能损伤评分也越来越受到重视,是判断药效的最重要指标之一。本文介绍了评价神经功能损伤的几种常见试验和评分标准,并认为在中医药治疗脑梗塞临床前研究中,应更加重视神经功能评分,充分体现中医药的优势。 Cerebral ischemia,which have a strong negative impact on patients life quality,is an increasing disease in recent years.During clinical treatment,neurological deficit scoring is an important index of evaluation both on diagnosis and healing effect.While in preclinical research,scoring system has been attached more and more importance since it is one of the major parameter for medicine efficacy evaluation.This article is aimed to introduce several experiments and scoring criteria which are widely used in ischemia research;and conclude that neurological deficit rating system should be highlighted and optimized in experimental study to carry forward advantages of integrated medicine in improving cerebral ischemia.
作者 程发峰 宋文婷 郭少英 钟相根 鲁艺 王庆国
机构地区 北京中医药大学基础医学院 中国中医科学院西苑医院
出处 《中国比较医学杂志》 CAS 2011年第3期43-48,共6页 Chinese Journal of Comparative Medicine
基金 "重大新药创制"科技重大专项(No.2009ZX09102-136) 国家自然科学基金项目(No.90709051)
关键词 脑缺血 神经功能评分 神经功能损伤 Cerebral ischemia Neurological function scoring Neurological deficit
分类号 R332 [医药卫生—人体生理学]
  • 相关文献

参考文献39

  • 1Willing AE. Experimental models: help or hindrance. Stroke, 2009 Mar;40(3 Suppl) :S152 -4.
  • 2Fisher M, Feuerstein G, Howells DW, Hum PD, Kent TA, Savitz SI, et al. Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations [ J ]. Stroke, 2009 Feb 26.
  • 3RotherJ. Neuroprotection does not work! Stroke; a journal of cerebral circulation [ J ]. 2008 Feb ;39 (2) :523 - 4.
  • 4Recommendations for standards regarding preclinical neuroprotective and restorative drug development [ J ]. Stroke, 1999 Dec;30(12) :2752 -8.
  • 5Bederson JB, Pitts LH, Tsuji M, Nishimara MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination [ J ]. Stroke, 1986 May -Jun ; 17 (3) :472 - 6.
  • 6Combs DJ, D'Alecy LG. Motor performance in rats exposed to severe forebrain ischemia : effect of fasting and 1,3-butanediol [J]. Stroke,1987 Mar-Apr;18(2) :503 -11.
  • 7Hernandez TD, Schallert T. Seizures and recovery from experimental brain damage [ J ]. Experimental neurology, 1988 Dee;102(3) :318 -24.
  • 8Ding Y, Zhou Y, Lai Q, Li J, Gordon V, Diaz FG. Long - term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment[J]. Brain research. 2001 Oct 12;915(2) :210 -7.
  • 9Kim MG, Choi JH, Lira JP, Kim DK, Shin TY, Boo Y, et al. Protective effects of a novel herbal decoction on focal cerebral ischemia in a rodent model[ J]. Neurological research. 2007 ;29 Suppl 1 :S16 -22.
  • 10Klintsova AY, Cowell RM, Swain RA, Napper RM, Goodlett CR, Greenough WT. Therapeutic effects of complex motor training on motor performance deficits induced by neonatal bingelike alcohol exposure in rats . I. Behavioral results [ J]. Brain research. 1998 Jul 27 ;800( 1 ) :48 - 61.

二级参考文献18

  • 1Bederson JB, Pitts LH, Tsuji M, Nisiimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion:evaluation of the model and development of a neurologic examination. Stroke 1986; 17:472 -476.
  • 2Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84-91.
  • 3Tatlisumak T, Takano K, Carano RA, Miller LP, Foster AC, Fisher M. Delayed treatment with an adenosine kinase inhibitor, GP683, attenuates infarct size in rats with temporary middle cerebral artery occlusion. Stroke 1998;29:1952 - 1958.
  • 4Yonemori F, Yamaguchi T, Yamada H, Tamura A.Evaluation of a motor deficit after chronic focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1998; 18:1099 - 1106.
  • 5Petullo D, Masonic K, Lincoln C, Wibberley L, Teliska M, Yao DL. Model development and behavioral assessment of focal cerebral ischemia in rats. Life Sciences 1999 ;64:1099 - 1108.
  • 6de Courten Myers GM, Kleinholz M, Wagner KR, Myers RE. Stroke assessment: morphometric infarct size versus neurologic deficit. J Neurosci Methods 1998; 83: 151 -157.
  • 7Sarraf-Yazdi S, Sheng H, Brinkhous AD, Pearlstein RD,Warner DS. Effects of postischemic halothane administration on outcome from transient focal cerebral ischemia in the rat. J Neurosurg Anesthesiol 1999;11:31 -36.
  • 8Yonemori F, Yamaguchi T, Nakayama H, Narita K, Hojo S, Tamura A. Effect of JTP-2942, a novel thyrotropinreleasing hormone analog, on motor deficits after chronic focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2000 ;20:74 - 81.
  • 9Hattori K, Lee H, Hurn PD, Crain B J, Traystman R J,DeVries AC. Cognitive deficits after focal cerebral ischemia in mice. Stroke 2000;31:1939 - 1944.
  • 10Hunter AJ, Hatcher J, Virley D, Nelson P, Irving E,Hadingham SJ, Parsons AA. Functional assessments in mice and rats after focal stroke. Neuropharmacol 2000;39:806 - 816.

共引文献20904

同被引文献196

引证文献20

二级引证文献142

中国比较医学杂志
2011年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部